Jianfei Shi

发表

Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A

Lili Mi, Lianhui Lei, Xiaolei Yin, 2020, Bioscience reports.

Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index.

Lili Mi, Xiaolei Yin, Ning Li, 2022, Future oncology.

Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs

Shenglei Zhang, Jinsheng Xu, Lili Mi, 2020, International Journal of Colorectal Disease.

Clinical significance of novel identified high‐frequency tumor‐specific peptides associated signature in predicting disease status of gastric cancer patients

Zibo Li, Xiaolei Yin, Ning Li, 2021, BioFactors.

18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Metabolic Parameters Before and After Neoadjuvant Chemotherapy Can Predict the Postoperative Prognosis of Locally Advanced Gastric Cancer.

Xinming Zhao, Lili Mi, Xiaolei Yin, 2020, Cancer biotherapy & radiopharmaceuticals.

Matrine promotes hepatic oval cells differentiation into hepatocytes and alleviates liver injury by suppression of Notch signalling pathway.

Jinsheng Xu, Lili Mi, Xiaolei Yin, 2020, Life sciences.

Matrine prevents the early development of hepatocellular carcinoma like lesions in rat liver

Jinsheng Xu, Lili Mi, Ning Li, 2019, Experimental and therapeutic medicine.

Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients

Jiyuan Zhang, Zheng Zhang, Z. Zou, 2011, Hepatology.

Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute‐on‐Chronic Liver Failure Patients

Zheng Zhang, Z. Zou, R. Xu, 2012, Stem cells translational medicine.

Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma

Jiyuan Zhang, Zheng Zhang, Jun‐liang Fu, 2013, Hepatology.

Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer.

B. Shan, Lili Mi, Ning Li, 2019, Future oncology.

Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells

Lili Mi, Ning Li, Jianfei Shi, 2022, Frontiers in Oncology.

Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China.

Zheng Zhang, Lei Jin, Fu-Sheng Wang, 2015, International journal of clinical and experimental medicine.

Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib

Lili Mi, Ning Li, Jianfei Shi, 2023, Technology in cancer research & treatment.

Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway

Z. Sha, Jianhua Wu, Zhanjun Guo, 2023, Clinical Medicine Insights. Oncology.

Molecular typing and mutational characterization of rectal neuroendocrine neoplasms

Lili Mi, Ning Li, Jianfei Shi, 2023, Cancer medicine.

Matrine improves the hepatic microenvironment and reverses epithelial-mesenchymal transition in hepatocellular carcinoma by inhibiting the Wnt-1/β-catenin signaling pathway.

Lili Mi, Ning Li, Jianfei Shi, 2023, American journal of translational research.

Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only

Lili Mi, Ning Li, Jianfei Shi, 2018, Oncology letters.

Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma

Jiyuan Zhang, Zheng Zhang, Jun‐liang Fu, 2013, Hepatology.